May 14, 2018 / 8:13 PM / 4 months ago

BRIEF-Dicerna Pharmaceuticals Q1 Loss Per Share $0.30

May 14 (Reuters) - Dicerna Pharmaceuticals Inc:

* DICERNA REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS AND PROVIDES CORPORATE UPDATE

* DICERNA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.30

* DICERNA PHARMACEUTICALS INC - BELIEVES THAT IT HAS SUFFICIENT CASH TO FUND EXECUTION OF ITS CURRENT CLINICAL AND OPERATING PLAN THROUGH 2019

* DICERNA PHARMACEUTICALS INC - FOR THREE-MONTH PERIOD ENDED MARCH 31, 2018, DICERNA RECOGNIZED $1.5 MILLION OF REVENUE ASSOCIATED WITH BI AGREEMENT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below